N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide

Base Information

Chemical Name:N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide
CAS No.:200562-23-8
Molecular Formula:C₄₆H₄₂N₆O₁₀
Molecular Weight:838.874
Hs Code.:

N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide

Synonyms:N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide

Suppliers and Price of N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide

Supply Marketing:

Business phase:: The product has achieved commercial mass production^*data from LookChem market partment

Manufacturers and distributors:

Manufacture/Brand
Chemicals and raw materials
Packaging
price

Total 0 raw suppliers

Chemical Property of N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide

Chemical Property:

Purity/Quality:

Safty Information:

Pictogram(s):
Hazard Codes:

MSDS Files:

Useful:

Technology Process of N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide

There total 4 articles about N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield:

: 4005-49-6
N-benzoyladenine

: 200562-23-8
N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide

Guidance literature:: Multi-step reaction with 3 steps

1: 91 percent / BSA, SnCl₄ / acetonitrile / 2 h / 60 °C

2: 1.) (i-Pr)2NEt; 2.) 10N aq. NaOH / 1.) CH₂Cl₂, r.t., 30 min; 2.) CH₂Cl₂, THF, MeOH, 4 deg C, 25 min

3: 1.) (i-Pr)2NEt, Bu₂SnCl₂ / 1.) CH₂Cl₂, r.t., 90 min; 2.) CH₂Cl₂, 80 deg C, 20 min

With benzenesulfonamide; sodium hydroxide; dibutyltin chloride; tin(IV) chloride; N-ethyl-N,N-diisopropylamine; In acetonitrile;
DOI:10.1002/hlca.19970800803

Reference yield:

: 40615-36-9
4,4'-dimethoxytrityl chloride

: 200562-23-8
N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide

Guidance literature:: Multi-step reaction with 2 steps

1: 1.) (i-Pr)2NEt; 2.) 10N aq. NaOH / 1.) CH₂Cl₂, r.t., 30 min; 2.) CH₂Cl₂, THF, MeOH, 4 deg C, 25 min

2: 1.) (i-Pr)2NEt, Bu₂SnCl₂ / 1.) CH₂Cl₂, r.t., 90 min; 2.) CH₂Cl₂, 80 deg C, 20 min

With sodium hydroxide; dibutyltin chloride; N-ethyl-N,N-diisopropylamine;
DOI:10.1002/hlca.19970800803

Reference yield:

: 200562-12-5
N⁶,2',3'-O-tribenzoyl-L-adenosine

: 200562-23-8
N-{9-[(2S,3S,4S,5S)-5-[Bis-(4-methoxy-phenyl)-phenyl-methoxymethyl]-4-hydroxy-3-(2-nitro-benzyloxymethoxy)-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide

Guidance literature:: Multi-step reaction with 2 steps

1: 1.) (i-Pr)2NEt; 2.) 10N aq. NaOH / 1.) CH₂Cl₂, r.t., 30 min; 2.) CH₂Cl₂, THF, MeOH, 4 deg C, 25 min

2: 1.) (i-Pr)2NEt, Bu₂SnCl₂ / 1.) CH₂Cl₂, r.t., 90 min; 2.) CH₂Cl₂, 80 deg C, 20 min

With sodium hydroxide; dibutyltin chloride; N-ethyl-N,N-diisopropylamine;
DOI:10.1002/hlca.19970800803